Zobrazeno 1 - 7
of 7
pro vyhledávání: '"JIHANA SHAJAHAN"'
Autor:
JIHANA SHAJAHAN
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 15, Iss 2, Pp FC04-FC08 (2021)
Introduction: Concomitant use of several drugs for a patient is often necessary for achieving therapeutic response. Understanding the profile of Drug-Drug Interactions (DDI) will help health care providers to optimise therapy for better patient o
Externí odkaz:
https://doaj.org/article/331f5158926d463abbd095beae13709a
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 9, Iss 12, Pp FC01-FC06 (2015)
Introduction: A 5-flurouracil, Adriamycin, Cyclophosphamide (FAC) and Adriamycin, Paclitaxel (AT) are two popular chemotherapeutic regimens for treatment of breast carcinoma. The most time tested and popular regimen is FAC. It is extensively stud
Externí odkaz:
https://doaj.org/article/bdf636e467cc40eabbb2b4527b90e4d0
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :41-46
Objective: The objective of the study was to analyze the pattern and risk factors of adverse drug reactions (ADR) in a tertiary care hospital. Methods: In this retrospective study, all the suspected ADRs reported to ADR monitoring center were analyze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39a04b9a53c9309db810956f338c7bad
https://doi.org/10.22159/ajpcr.2022.v15i9.45303
https://doi.org/10.22159/ajpcr.2022.v15i9.45303
AN ANALYSIS OF THE PREVALENCE OF POLYPHARMACY AMONG INPATIENTS OF A TERTIARY CARE HOSPITAL IN KERALA
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :68-71
Objectives: The aim of the study was to estimate the prevalence of polypharmacy, identify the age groups commonly associated with polypharmacy, study the correlation between duration of hospital stay and polypharmacy, and identify the diseases common
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d21393d99e2e8caa2c5fb29c7e04a80
https://doi.org/10.22159/ajpcr.2022.v15i5.44479
https://doi.org/10.22159/ajpcr.2022.v15i5.44479
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 7:2433
Background: Adverse drug reactions (ADR) are the leading cause of mortality and morbidity in all health care systems. Hospital based ADR monitoring and reporting programmes can throw some light upon the profile of ADRs and ways to prevent them, facil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b729aef176aa5b5c252954f1b2db9a3
https://doi.org/10.18203/2319-2003.ijbcp20184861
https://doi.org/10.18203/2319-2003.ijbcp20184861
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 7:1715
Background: Adverse drug reactions (ADRs) are an important concern in modern therapeutics. Due to limitations in identifying ADRs during research phase, organized post marketing studies are essential. However, there are only few recent studies on thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7638ebf6504c30973e1d6534fe72f56
https://doi.org/10.18203/2319-2003.ijbcp20183477
https://doi.org/10.18203/2319-2003.ijbcp20183477
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 6:2911
Background: Pharmacovigilance is the science and activities related to detection, assessment, understanding and prevention of adverse drug reactions (ADR). The major challenge faced by the pharmacovigilance programme of India is underreporting. It is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3833dd77b7fef66b03710d5988848da8
https://doi.org/10.18203/2319-2003.ijbcp20175217
https://doi.org/10.18203/2319-2003.ijbcp20175217